These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7139983)
1. [Hypercalcemia in malignancy]. Kimura S; Tanaka M; Adachi I; Abe K Horumon To Rinsho; 1982 Aug; 30(8):827-32. PubMed ID: 7139983 [No Abstract] [Full Text] [Related]
2. Hypercalcemia of malignancy: pathophysiology and implications for treatment. Theriault RL Oncology (Williston Park); 1993 Jan; 7(1):47-50; discussion 52-5. PubMed ID: 8420542 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy. Coleman RE Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153 [TBL] [Abstract][Full Text] [Related]
4. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases. de Vernejoul MC Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953 [No Abstract] [Full Text] [Related]
9. [Hypercalcemia and skeletal engagement in malignancy--development and therapeutic possibilities]. Ljunghall S; Bergh J; Rastad J; Akerström G Lakartidningen; 1989 May; 86(21):1991-3. PubMed ID: 2733514 [No Abstract] [Full Text] [Related]
10. [Biphosphonates in oncology]. Khosravi Shahi P; Díaz Muñoz de la Espada V An Med Interna; 2005 Nov; 22(11):544-7. PubMed ID: 16454591 [TBL] [Abstract][Full Text] [Related]
11. Cancer hypercalcemia: recent advances in understanding and treatment. Body JJ Eur J Cancer Clin Oncol; 1984 Jul; 20(7):865-9. PubMed ID: 6378642 [No Abstract] [Full Text] [Related]
12. Mechanisms and treatment of hypercalcemia of malignancy. Clines GA Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221 [TBL] [Abstract][Full Text] [Related]
13. Hypercalcemia of malignancy. Insogna KL; Broadus AE Annu Rev Med; 1987; 38():241-56. PubMed ID: 3555293 [TBL] [Abstract][Full Text] [Related]
14. Gallium in the treatment of hypercalcemia and bone metastasis. Warrell RP; Bockman RS Important Adv Oncol; 1989; ():205-20. PubMed ID: 2651289 [No Abstract] [Full Text] [Related]
15. Hypercalcemia of malignancy. Mundy GR; Guise TA Am J Med; 1997 Aug; 103(2):134-45. PubMed ID: 9274897 [No Abstract] [Full Text] [Related]
16. Proceedings: Hypercalcemia in patients with malignant diseases and treatment with porcine calcitonin. Abe K; Adachi I Calcif Tissue Res; 1974; 15(2):153-4. PubMed ID: 4844388 [No Abstract] [Full Text] [Related]
18. Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw. Wynn RL Gen Dent; 2005; 53(6):392-5. PubMed ID: 16366043 [No Abstract] [Full Text] [Related]
19. [Treatment of malignancy associated hypercalcemia]. Tai N; Inoue D Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875 [TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of significance in the development of hypercalcemia in malignant disease]. Kristensen B; Holmegaard SN; Frølich A; Transbøl I Ugeskr Laeger; 1985 Mar; 147(11):935-8. PubMed ID: 3992688 [No Abstract] [Full Text] [Related] [Next] [New Search]